GENOCEA BIOSCIENCES, INC. 4

Accession 0001594631-17-000005

CIK 0001457612operating

Filed

May 21, 8:00 PM ET

Accepted

May 22, 4:47 PM ET

Size

24.1 KB

Accession

0001594631-17-000005

Form 4

Period: 2017-05-18

Director

Transactions

Exercise/Conversion
Common Stock
2017-05-18$2.38/sh+19,281$45,889→ 33,062 total
Exercise/Conversion
Common Stock
2017-05-19$2.86/sh+11,057$31,623→ 24,304 total
Exercise/Conversion
Common Stock
2017-05-18$2.38/sh+1,680$3,998→ 3,697 total
Purchase
Common Stock
2017-05-18$6.02/sh−31,045$186,891→ 2,017 total
Exercise/Conversion
Common Stock
2017-05-19$2.38/sh+11,230$26,727→ 13,247 total
Exercise/Conversion
Common Stock
2017-05-18$1.67/sh+10,084$16,840→ 13,781 total
Purchase
Common Stock
2017-05-19$6.07/sh−22,287$135,282→ 2,017 total
Exercise/Conversion
Option to purchase Common Stock
2017-05-18$1.67/sh−10,084$16,840→ 0 total
Exercise: $1.67Exp: 2017-06-12→ Common Stock (10,084 underlying)
Exercise/Conversion
Option to purchase Common Stock
2017-05-18$2.38/sh−1,680$3,998→ 0 total
Exercise: $2.38Exp: 2018-06-18→ Common Stock (1,680 underlying)
Exercise/Conversion
Option to purchase Common Stock
2017-05-18$2.38/sh−19,281$45,889→ 11,230 total
Exercise: $2.38Exp: 2019-06-30→ Common Stock (19,281 underlying)
Exercise/Conversion
Option to purchase Common Stock
2017-05-19$2.38/sh−11,230$26,727→ 0 total
Exercise: $2.38Exp: 2019-06-30→ Common Stock (11,230 underlying)
Exercise/Conversion
Option to purchase Common Stock
2017-05-19$2.86/sh−11,057$31,623→ 0 total
Exercise: $2.86Exp: 2020-12-17→ Common Stock (11,057 underlying)

Footnotes (5)

[F1]The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $6.00 to $6.05, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
[F2]The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $6.00 to $6.15, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
[F3]The options of registrant's common stock vested as to 25% of the shares on the one-year anniversary of the grant and in equal monthly installments over the next three years thereafter.
[F4]The options of registrant's common stock vested in equal monthly installments over the first four years after the grant.
[F5]The options of registrant's common stock vested on the date of the grant.

Documents

1 file

GENOCEA BIOSCIENCES, INC.

CIK 0001457612

Entity typeoperating

IncorporatedDE